NMA: Nonprescription Medicines Academy

Recent Self Care News

  • Recall of Dayquil Cold & Flu 24-Count Liquicaps Bonus Pack

    The Procter & Gamble Company is voluntarily recalling its Vicks® DayQuil® Cold & Flu 24-Count LiquiCaps Bonus Pack in the United States. Consumers should stop using the recalled product.

    P&G is taking this action because this product does not contain a child-resistant backing for the blister packs in the box, despite label statements that the product is in child-resistant packaging.

    December 29th, 2009

  • Patient Safety Alerts

    • Bayer Consumer Care has recalled a single product lot (#296939L, expiration May 2011) of the combination package of Alka-Seltzer Plus Day & Night Cold Formula Liquid Gels. The labeling on the foil blister card of certain packages within the lot was printed with the label reversed: the label for the green Night product appears under some of the blue Day product and vice versa. Consumers using the affected product lot may not be aware of the warnings of an antihistamine in the product that could cause drowsiness.

    December 21st, 2009

  • New Product Alerts

    Zegerid OTC
    The FDA has approved an Rx-to-OTC switch of Zegerid, an immediate-release formulation of the proton pump inhibitor omeprazole. Zegerid combines omeprazole 20 mg with sodium bicarbonate 1,100 mg; the sodium bicarbonate raises the gastric pH, thereby protecting omeprazole from acid degradation. The product will be marketed as Zegerid OTC by Schering-Plough HealthCare Products Inc.

    Nutrisystem D Available Through Walgreens

    December 21st, 2009

  • New Tools Predict Patient Risk for Diabetes, Osteoporotic Fractures

    In separate articles, researchers describe a new patient self-assessment diabetes screening score and two new algorithms for predicting a person’s 10-year risk for osteoporotic or hip fracture.

    December 21st, 2009

  • Milk Thistle May Reduce Chemotherapy-Induced Hepatotoxicity

    The first randomized, controlled clinical study to investigate the feasibility and safety of the dietary supplement milk thistle (Silybum marianum) for the treatment of chemotherapy-induced hepatotoxicity in children with acute lymphoblastic leukemia (ALL) reported a trend toward significant reductions in liver toxicity. The study results were published online December 14, 2009, in Cancer.

    December 21st, 2009

  • Blood Pressure Control Better With Pharmacist–Physician Collaboration

    A community-based intervention involving physician and pharmacist collaboration produced significant improvement in blood pressure control compared with usual care, according to the results of a prospective, cluster randomized, controlled clinical trial reported in the November 23, 2009, issue of Archives of Internal Medicine.

    December 21st, 2009

  • New iPhone App Helps Consumers Select OTC Medications

    PICKKA—a division of the Silicon Valley company Evincii, which developed the in-store PHARMAssist guided search kiosk—has launched PICKKA Med, a free iPhone application that helps consumers select nonprescription medications based on the patient’s symptoms, age, and known allergies or contraindications. The application, which PICKKA describes as “an expert pharmacist in your product,” also is accessible from mobile browsers and online at www.pickka.com.

    December 21st, 2009

  • New Year Good Time for Cleaning Out Medicine Cabinets

    In a recent media release, the American Pharmacists Association (APhA) reminded pharmacists and consumers that the new year is a good time to conduct an annual cleaning and purging of home medicine cabinets and other medication storage areas. APhA offered consumers the following tips for conducting this task:
    • Check the date on everything in your medicine cabinet and dispose of anything that has passed the expiration date.
    • Properly dispose of anything you have not used in the past 12 months.

    December 21st, 2009

  • New Product Alerts

    Pepto-Bismol Chewable Tablets With InstaCool
    Pepto-Bismol chewable tablets are now available in a peppermint-flavored InstaCool formulation that provides a powerful, instant cooling sensation. The cooling sensation is intended to signal that “relief is on its way.”

    Dayquil Mucus Control DM
    Procter & Gamble has introduced Dayquil Mucus Control DM, a combination liquid product containing the cough suppressant dextromethorphan (10 mg/15 mL) and the expectorant guaifenesin (200 mg/15 mL). It is labeled for use in patients 6 years of age and older.

    Robitussin To Go

    November 30th, 2009

  • News Briefs

    • A retrospective review of the medical records of 1,786 patients in southern England found that wearing contact lenses remains the most important risk factor for infectious corneal ulcers. Contact lens wear was the main predisposing factor in nearly one third (31%) of cases. The authors urged continuous education of both patients and professionals to reduce the rate and severity of infectious keratitis. (Br J Ophthalmol. 2009;93:1319-24.)

    November 30th, 2009